Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 32
- Q1 2023, −1 vs. previous quarter
- 13F value
- $3.78M
- Reported value at the end of Q1 2023
- Superinvestors holding
- 0
- At the end of Q1 2023
Superinvestors holding ONCR, Q1 2023
No superinvestor reported holding ONCR at the end of Q1 2023.
Latest insider trades
Open-market purchases and sales by Oncorus, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2022 (view filing)7:16 PM ET | Dec 28-30 | 2 days | Deerfield Management Company, L.P. and 7 others10% Owner, Other: Possible Member of 10% Group | SSale | −336.2K | $0.2625 | −$88.3K | −54.2%284.7K after | 9 lots |
| Dec 27, 2022 (view filing)6:33 PM ET | Dec 22-27 | 5 days | Deerfield Management Company, L.P. and 7 others10% Owner, Other: Possible Member of 10% Group | SSale | −73.4K | $0.2711 | −$19.9K | −18.6%321.6K after | 6 lots |
| Dec 21, 2022 (view filing)7:09 PM ET | Dec 19-21 | 2 days | Deerfield Management Company, L.P. and 7 others10% Owner, Other: *Possible Member of 10% Group | SSale | −128.3K | $0.2934 | −$37.6K | −28.0%329.6K after | 9 lots |
| Dec 15, 2022 (view filing)6:50 PM ET | Dec 13-15 | 2 days | Deerfield Management Company, L.P. and 7 others10% Owner, Other: *Possible Member of 10% Group | SSale | −13.8K | $0.3868 | −$5.33K | −3.9%343.7K after | 9 lots |
| May 25, 2022 (view filing) | May 25 | Same day | Wanstall RickCFO and Treasurer | PPurchase | +3.78K | $1.20 | +$4.53K | +8.0%51.0K after | |
| May 24, 2022 (view filing) | May 20 | 4 days | Wanstall RickCFO and Treasurer | PPurchase | +1.61K | $1.20 | +$1.93K | +3.5%47.2K after | |
| May 19, 2022 (view filing) | May 17-19 | 2 days | Wanstall RickCFO and Treasurer | PPurchase | +5.00K | $1.29 | +$6.45K | +12.3%45.6K after | 2 lots |
| May 16, 2022 (view filing) | May 12-16 | 4 days | Wanstall RickCFO and Treasurer | PPurchase | +38.6K | $1.14 | +$44.0K | +1,930.6%40.6K after | 3 lots |
| Nov 17, 2021 (view filing) | Nov 16 | 1 day | Harbin StephenCOO and Chief of Staff | PPurchase | +15.0K | $5.80 | +$87.0K | New position15.0K after | |
| Nov 17, 2021 (view filing) | Nov 16 | 1 day | Harbin StephenCOO and Chief of Staff | PPurchase | +15.0K | $5.78 | +$86.7K | New position15.0K after |
Top 10 13F holders, Q1 2023
The largest institutional positions in Oncorus, Inc. at the end of Q1 2023; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Asset Management LLC | 2,849,464 | $980.2K | 0.41% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,377,031 | $817.7K | 0.21% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,367,436 | $814.6K | 0.22% | 00.0% | Unchanged |
| Fosun International Ltd | 962,323 | $327.2K | 0.03% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 540,258 | $185.9K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 475,345 | $163.6K | 0.00% | −20,568−4.1% | Reduced |
| Millennium Management LLC | 286,667 | $99.0K | 0.00% | +10,309+3.7% | Added |
| Renaissance Technologies LLC | 144,000 | $50.0K | 0.00% | −142,936−49.8% | Reduced |
| BlackRock Inc. | 139,040 | $47.8K | 0.00% | −632−0.5% | Reduced |
| Geode Capital Management, LLC | 135,751 | $46.7K | 0.00% | −2,176−1.6% | Reduced |